Support WBURJohnson & Johnson, Eli Lilly Pause COVID-19 Drug TrialsLaurel WamsleyVanessa RomoOctober 13, 2020 ShareThe phase 3 trial of Johnson & Johnson's COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant's "unexplained illness." (AP)